HIV Testing -- what we need to know Dr Madhusree Ghosh ST6 Community Sexual and Reproductive Health.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Pregnancy and complex social factors
For primary and secondary care settings
SPAIIN Where are we now?. Key concepts in clinical networks Equitable Efficient High quality Locally delivered Patient/Carer involvement ‘designed to.
HIV Counselling and Testing
March 2010 Overview of NAT and HIV Testing in the UK Deborah Jack, Chief Executive, NAT.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Diagnosis and Management of Acute HIV Infection HIV Clinical Guidelines from the New York State Department of Health AIDS Institute January 2010 HIV CLINICAL.
Perspectives on Outreach from the NYC Department of Health and Mental Hygiene Benjamin Tsoi, MD, MPH Bureau of HIV/AIDS Prevention and Control NYC Department.
NHS Croydon Claire Godfrey AD Adult Strategic Commissioning.
Referral of participants for HIV follow-up care Africa Centre MDP experiences Presented by: Hlengiwe Ndlovu MDP Clinic coordinator.
CDC Recommendations for HIV Testing of Adults and Adolescents Christina Price, MPH Delta Region AIDS Education and Training Center.
Version 11Page 1 of 6 Improving Identification of Patients Infected with HIV Using Rapid Testing in the Emergency Department: A Systems-Based Approach.
Improving HIV case detection Steve Baguley Genitourinary physician, Aberdeen.
HIV Testing in Health-Care Settings
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Prevention and Management of Sexually Transmitted Diseases in Persons Living with HIV/AIDS Partner Management.
The case for increasing HIV testing in all medical settings 1.
Introduction PRO(TECT) is a partnership project between Terrence Higgins Trust and The Claude Nicol Clinic (CNC) GUM in Brighton. It provides a new tailor-made.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
© Aahung 2004 Millennium Development Goals Expanding the Agenda:
HIV Testing in Health- Care Settings Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings U.S. Centers.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Module 6: Routine HIV Testing of TB Patients. Learning Objectives Explain why TB suspects and patients should be routinely tested for HIV Summarize the.
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
HIV Rapid Testing Dr. Kevin Harvey National HIV/AIDS Programme Ministry of Health Jamaica.
HIV testing and diagnosis Dr Simon Ellis On behalf of the Audit & Standards Sub-Committee.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
Perinatal HIV Testing in Utah Lois Blobaum, BSN, Theresa Garrett, MSN and Nan Streeter, RN, MS Utah Department of Health.
Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.
Universal HIV Testing Closing the Gap Peter A. Leone, MD Associate Professor of Medicine University of North Carolina Medical Director, NC HIV/STD Prevention.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
HIV TESTING IN PRIMARY CARE. AIM To provide information enabling any clinician to perform an HIV test within good clinical practice and to encourage normalisation.
San Francisco Department of Public Health HIV Partner Services Update 2011 San Francisco STD Prevention and Control Services May 2011.
NHS Tayside HIV Testing Guideline May 2013
RCGP training online: new training in short bites Danny Morris, Expert Lead RCGP Hepatitis B and C Part 1.
The Policy Company Limited © Control of Infection.
Immigration Removal Centres and HIV Joe Murray Policy Officer National AIDS Trust.
National Audit Group National Audit of Sexual Healthcare for People with HIV Infection National Audit Group British Association for Sexual Health & HIV.
Mr X and Mr Y 1 Case 4: July year-old Caucasian man ‘Mr X’ 2.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
STDs among Men who Have Sex with Men (MSM), San Francisco 2007—2010 STD Prevention and Control Services San Francisco Department of Public Health.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Introduction to the.... HIV in the UK Over a quarter of those infected remain undiagnosed – HPA 35% of HIV-related deaths attributable to late diagnosis.
Routine Opt-Out HIV Testing Texas STD Clinics James H. Lee, Senior Public Health Advisor HIV/STD Program Texas Department of State Health Services.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
CDAT & Sexual Health Pamela Jones & Alison Collins Clinical Nurse Specialists Integrated Contraception and Sexual Health Services.
Introduction to OraQuick Rapid HIV Testing William F. Ryan Community Health Center School Based Health Program.
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and.
SEXUAL HEALTH: SCREENING, VACCINES AND REFERRALS Dr Kate Morton.
Research Study Gavin Bryce Health Promotion Specialist NHS Brighton and Hove Provider-initiated HIV testing in primary care.
A Universal Testing Programme for Blood Borne Viruses in an Urban Emergency Department – a call for widespread ED testing in Ireland S O’Connell 1, D Lillis.
The Prevalence of Chlamydia Infection in Youth Offenders in HMP/YOI Holloway June 2003 – June 2005 THERESA BURNS, SEXUAL HEALTH ADVISER Women’s Health.
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
Sexual Health: where we are now and our vision for the future Dr. Mayada Abu Affan.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
1 Module 2: HIV Counseling and Testing for PMTCT Ministry of Health/HAPCO, Ethiopia.
ANALYZING THE INTEGRATION OF HIV TESTING INTO THE FLOW OF FAMILY PLANNING CLINICS JANUARY 29, 2009 Rapid Testing & Clinic Flow 1.
HIV testing guidance: know, treat, prevent
Karen barclay Health Adviser
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Presentation transcript:

HIV Testing -- what we need to know Dr Madhusree Ghosh ST6 Community Sexual and Reproductive Health

Why it is important HIV is a treatable medical condition A significant number of people in the United Kingdom are unaware of their HIV infection. Late diagnosis is the most important factor associated with HIV- related morbidity and mortality in the UK. Patients should therefore be offered and encouraged to accept HIV testing in a wider range of settings. Patients with specific indicator conditions should be routinely recommended to have an HIV test. All doctors, nurses and midwives should be able to obtain informed consent for an HIV test in the same way that they currently do for any other medical investigation.

Background A national audit by the British HIV Association (BHIVA) showed that 24 per cent of deaths occurring amongst HIV-positive adults in the UK in 2006 were directly attributable to the diagnosis of HIV being made too late for effective treatment. Many of these ‘late presenters’ have been seen in the recent past by healthcare professionals without the diagnosis having been made.

Background continued Late diagnosis of HIV infection has been associated with increased mortality and morbidity impaired response to HAART and increased cost to healthcare services. From a public health perspective, knowledge of HIV status is associated with a reduction in risk behavior and reduced onward transmission.

National Strategy for Sexual Health and HIV (2001) Recommendations All attendees at GUM clinics should be offered an HIV test -- the proportion of infections which remain undiagnosed has reduced but still remains significant [25% in heterosexuals, 47% in men who have sex with men (MSM)]. A universal ‘opt–out’ approach to HIV testing in antenatal patients.

Confidentiality and HIV testing Results should be given directly by the testing clinician to the patient and not via any third party

Recommendations for testing Who can test? It should be within the competence of any doctor, midwife, nurse or trained healthcare worker to obtain consent for and conduct an HIV test.

Who should be offered a test? Universal HIV testing is recommended in all of the following settings: GUM or sexual health clinics antenatal services termination of pregnancy services drug dependency programmes healthcare services for those diagnosed with tuberculosis, hepatitis B, hepatitis C and lymphoma.

Who should be offered a test? continued An HIV test should be considered in the following settings where diagnosed HIV prevalence in the local population (PCT/LA) exceeds 2 in 1000 population all men and women registering in general practice all general medical admissions. HIV testing should also be routinely performed in the following groups in accordance with existing Department of Health guidance: blood donors dialysis patients organ transplant donors and recipients.

How often to test? Repeat testing should be provided for the following groups: all individuals who have tested HIV negative but where a possible exposure has occurred within the window period men who have sex with men (MSM) – annually or more frequently if clinical symptoms are suggestive of seroconversion or ongoing high risk exposure injecting drug users – annually or more frequently if clinical symptoms are suggestive of seroconversion antenatal care – women who refuse an HIV test at booking should be re-offered a test, and should they decline again a third offer of a test should be made at 36 weeks. Women presenting to services for the first time in labour should be offered a point of care test (POCT).

Clinical indicator diseases for adult HIV infection

Which test to use? Two types: Venepuncture (screening assay where blood is sent to a laboratory for testing) or Rapid point of care test (PoCT).

Blood tests The recommended first-line assay is one which tests for HIV antibody AND p24 antigen simultaneously. These are termed fourth generation assays, and have the advantage of reducing the time between infection and testing HIV positive to one month Laboratories undertaking screening tests should be able to confirm antibody and antigen/RNA.

Point of care testing (PoCT) Advantage : Result from either a finger-prick or mouth swab sample within minutes. Ease of use when venepuncture is not possible. Due to the low specificity of PoCT results must be confirmed by serological tests as there will be false positives.

Recommendations for PoCT Clinical settings where a rapid turnaround of testing results is desirable Community testing sites Urgent source testing in cases of exposure incidents Circumstances in which venepuncture is refused.

PoCT in LLR PoCT is available in the community at ISH, Saunas, TRADE (representing the organisation for LGBT), LASS (Leicestershire AIDS Support Service), an independent voluntary organization providing service for people affected by HIV/AIDS in Leicester city. ISH, TRADE and LASS also link into the HIV clinical governance group. The test.hiv service is the Nationally commissioned provider of HIV home-sampling screening, and offers free HIV tests in participating regions.

Pre test discussion The benefits of testing to the individual Details of how the result will be given

Post-test discussion Arrangements for communicating the results should always be discussed and agreed with the patient at the time of testing Face-to-face provision of HIV test results is strongly encouraged for: ward-based patients patients more likely to have an HIV-positive result those with mental health issues or risk of suicide those for whom English is a second language young people under 16 years those who may be highly anxious or vulnerable.

Post-test discussion for individuals who test HIV negative Offer screening for sexually transmitted infections and advice around risk reduction behavior change including discussion relating to post-exposure prophylaxis (PEP) -- - onward referral to GUM or HIV services or voluntary sector agencies. Repeat HIV test if still within the window period.

Post-test discussion for individuals who test HIV positive Result should be given face to face in a confidential environment and in a clear and direct manner. If a positive result is being given by a non-GUM/HIV specialist, it is essential, prior to giving the result, to have clarified knowledge of local specialist services and have established a clear pathway for onward referral. Individual testing HIV positive for the first time is seen by a at the earliest possible opportunity, preferably within 48 hours and certainly within two weeks of receiving the result. More detailed post-test discussion will be performed by the GUM/HIV specialist team.

Suspected Primary HIV infection Primary HIV infection (PHI) or seroconversion illness occurs in approximately 80 per cent of individuals, typically two-to-four weeks after infection Must be recognised to prevent onward transmission. Features of PHI are non-specific frequently the diagnosis is missed or not suspected. The typical symptoms include a combination of any of: fever rash (maculopapular) myalgia pharyngitis headache/aseptic meningitis. These resolve spontaneously within two-to-three weeks and therefore if PHI is suspected, this needs to be investigated at the time of presentation.

Audit on Late Diagnosis of HIV Aim: To identify newly- diagnosed HIV positive patients between rates of ‘late’ diagnosis missed opportunities for testing Results: Out of 180 new HIV positive cases 85 were diagnosed late. The actual number of late diagnosis cases during the audit period is 47. Therefore, the actual late diagnosis rate in this period was 26%, instead of the reported 61% % cases had pre-existing HIV indicators, and 46% cases had missed opportunities of early diagnosis. Conclusions: Actual late-diagnosis rate is lower than that reported previously. There is a high percentage of missed opportunities, which warrants increasing the awareness of clinicians and general population for early detection of HIV.

Recommendations For Clinicians HIV testing must be undertaken rigorously as per the UK National guidelines. Regular update sessions for primary care clinicians by HIV specialists to recognise the symptoms that may signify primary HIV infection or illnesses that often co-exist with HIV. Missed cases must be discussed MDT meetings to raise awareness amongst tertiary care clinicians to identify high risk factors. Importance of partner notification and partner testing should be discussed with patients. Record keeping must be improved HIV treatment centers need to follow up all HIV positive patients and ensure continuity of care.

Recommendations For Commissioners GP practices in Leicester should be commissioned to offer screening to all new registrants. Outreach service and community HIV testing specifically targeted towards the high risk communities should be commissioned.

Thank you